First Time Loading...

Acorda Therapeutics Inc
NASDAQ:ACOR

Watchlist Manager
Acorda Therapeutics Inc Logo
Acorda Therapeutics Inc
NASDAQ:ACOR
Watchlist
Price: 0.7 USD 34.62%
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

ACOR Price Targets Summary
Acorda Therapeutics Inc

Wall Street analysts forecast ACOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACOR is 10 USD .

ACOR Lowest Forecast
Wall Street Target
Not Available
ACOR Average Forecast
Wall Street Target
10 USD
1 329% Upside
ACOR Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
10 USD
1 329% Upside
Highest
Price Target
Not Available
Acorda Therapeutics Inc Competitors:
Price Targets
ALERS
Eurobio Scientific SA
110% Upside
VYGR
Voyager Therapeutics Inc
107% Upside
GLPG
Galapagos NV
54% Upside
6160
Beigene Ltd
43% Upside
ALERS
Eurobio Scientific SA
110% Upside
VYGR
Voyager Therapeutics Inc
107% Upside
GLPG
Galapagos NV
54% Upside
6160
Beigene Ltd
43% Upside
KMDA
Kamada Ltd
118% Upside
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
70% Upside
CRIS
Curis Inc
38% Upside
T
TSBX
Turnstone Biologics Corp
314% Upside

Revenue
Forecast

Revenue Estimate
Acorda Therapeutics Inc

For the last 8 years the compound annual growth rate for Acorda Therapeutics Inc's revenue is -16%. The projected CAGR for the next 2 years is 18%.

-16%
Past Growth
18%
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Acorda Therapeutics Inc

Operating Income forecast
is not available for
Acorda Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Acorda Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ACOR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACOR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACOR stock valuation using valuation multiples.
Wall Street Estimates
ACOR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACOR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACOR's stock price target?
Price Target
10 USD

According to Wall Street analysts, the average 1-year price target for ACOR is 10 USD .

What is Acorda Therapeutics Inc's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Acorda Therapeutics Inc's revenue is -16%. The projected CAGR for the next 2 years is 18%.

ALPHA SPREAD
Join more than 135,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.